Skip to content
Traxsy
All articles

Injections

Pen splitting on GLP-1 pens: what the Instructions for Use say, and the risks

General information, not medical advice. Talk to your prescriber or pharmacist about your own treatment.

Safety note first: the Instructions for Use for the Ozempic® pen and the Zepbound® KwikPen® say not to set a dose by counting clicks. Only take the doses your prescriber has told you to take, set exactly as your pen's Instructions for Use describe. Any click count, including the estimates Traxsy shows, is not a dosing instruction.

Full article coming soon

This page is a short summary. The full article is still being written and checked against its sources.

Sources

  1. Ozempic® prescribing information, Medication Guide and Instructions for Use — Novo Nordisk (PDF)
  2. Zepbound® KwikPen® Instructions for Use — Eli Lilly (PDF)

Sources checked October 1, 2026

  • pen splitting
  • KwikPen Instructions for Use
  • GLP-1 pen safety
Traxsy

A GLP-1 medication tracker for iPhone. Log doses, weight and side effects, and see how they line up.

Coming soon to the App Store · iPhone

© 2026 Traxsy

Traxsy is a tracking tool and does not provide medical advice, diagnosis or treatment. Always follow your prescriber.

Ozempic®, Wegovy®, Rybelsus®, Victoza® and Saxenda® are trademarks of Novo Nordisk A/S. Mounjaro®, Zepbound® and Trulicity® are trademarks of Eli Lilly and Company. Traxsy is not affiliated with or endorsed by them.